Studies show that intra venous Adenosine infusion as an adjunct to reperfusion in the treatment of acute myocardial infarction associated with reduction of heart muscle damage 10, 11 .
Adenosine is a naturally occurring nucleoside with a half life in blood of less than 10 seconds. Adenosine may be administered via intravenous or Intracoronary route, produce hyperemic effect that is commonly used to measure the coronary flow reserve during PCI. The 20 . There is a evidence from previous study that despite a short serum half life the cardio-protective effect the effect of Intracoronary adenosine infusion in human subjects persist much longer 17 .
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Hyperaemic effect of Adenosine may be beneficial to ameliorate distal embolization of platelet thrombi following elective PCI. One study suggested that endogenous release of adenosine could compensate distal embolization of small particles 21 . The minimum dose is required to achieve minimum Fractional Flow Reserve (or maximum hyperaemia), 42 micro grams for both Left and Right Coronary artery in human without any significant side effect 22 . 50 micro grams bolus administration of adenosine through the guiding catheter before elective PCI to ameliorate distal embolization of relatively small platelet thrombi 6 , Although only a fraction of the administered adenosine would reach the target distal lesion, this above dosage (50 micro grams) and route of administration was sufficient to achieve maximum hyperaemia. Moreover, an Intracoronary bolus approach to administration, lower cost and reduce risk of bradycardia.
Adenosine induced hyperaemia can potentially ameliorates the deleterious effect of distal embolization associated with non-urgent elective Percutaneous Coronary Intervention (PCI) through dilatation of microvasculature. This may reduces capillary obstruction by facilitating the throughout passage of embolized platelet thrombi out to the venous end of coronary circulation, there by reduce the incidence of post procedural micro infraction and myonecrosis .
